Therapeutic effects of KRM-II-81, positive allosteric modulator for α2/3 subunit containing GABA<sub>A</sub> receptor, in mice model of Dravet syndrome.

○Kiyoshi Egawa

[3Pm-093] Therapeutic effects of KRM-II-81, positive allosteric modulator for α2/3 subunit containing GABA_A receptor, in mice model of Dravet syndrome.

○Kiyoshi Egawa¹, Sachiko Nakakubo¹, Shiraishi Hideaki¹, James Cook² (1. Pediatric derpt, Hokkaido Univ. Grad. Med., 2. Dept. of Chemistry, Univ. of Wisconsin- Milwaukee)

Keywords:Dravet syndrome, GABA receptor

Abstract password authentication.
A password is required to view the full text of the abstract. Please refer to the member site for the password.

https://membership.jnss.org/C00/login

Presentation information

[3Pm] Epilepsy

[3Pm-093] Therapeutic effects of KRM-II-81, positive allosteric modulator for α2/3 subunit containing GABA_A receptor, in mice model of Dravet syndrome.

Password

Presentation information

[3Pm] Epilepsy

[3Pm-093] Therapeutic effects of KRM-II-81, positive allosteric modulator for α2/3 subunit containing GABAA receptor, in mice model of Dravet syndrome.

Password

[3Pm-093] Therapeutic effects of KRM-II-81, positive allosteric modulator for α2/3 subunit containing GABA_A receptor, in mice model of Dravet syndrome.